Key points from article :
The preprint introduces “Cost-efficient whole genome-sequencing using natural sequencing-by-synthesis chemistry and open fluidics platform” —the UG 100.
“The first implementation produces 10 billion reads per run, with a turnaround time of under 20 hrs per run for 300 bp reads, at a price of $1/Gb.”
Ultima’s reads are longer than typical short reads.
Layer in almost $600 million in fundraising.
Gilad Almogy, Ultima’s founder and CEO, says "boundless genomic information will lead to scientific discoveries and improvements in human health far beyond what anyone can currently imagine.”
The authors from Ultima Genomics described a new next-generation sequencing (NGS) technology target $100 genome
